MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

Conditions

• Glabellar Lines
• Lateral Canthal Lines

Interventions

• DRUG: MT10109L Dose 1
• DRUG: MT10109L Dose 2
• DRUG: MT10109L Dose 1 + Dose 2

Sponsor

Medy-Tox